We came to Innolitics with a complex AI/ML CADx algorithm and an aggressive timeline. Honestly, we weren't sure it was possible.
Yujan and the Innolitics team turned that assumption upside down. Through their leadership, the combined Innolitics, Lunit, and Volpara Health team delivered a complete submission package—DHF, software documentation, clinical performance assessment, the full eSTAR—in 13 weeks!
What impressed me most wasn't just the speed. It was how they handled the complexity—both technical and organizational. Our device uses AI algorithms for diagnosis, which presented unique regulatory challenges. We also had a multi-national, cross-functional team that needed coordination across time zones and disciplines.
The Innolitics team managed all of it. They knew exactly how to position the device, which predicates to target, and how to draw the medical device versus MDDS boundaries in a way that held up under scrutiny. Most importantly, they structured the technical documentation so FDA reviewers could actually understand what we built without getting lost in the ML weeds.
That combination—deep regulatory knowledge, technical fluency, and the ability to keep a complex team moving in the same direction—is rare. Most consultants have one or two of those. Innolitics have all three. They didn't cut corners. Every deliverable was thorough, well-written, and backed by their deep knowledge of medicine, software engineering, and FDA expectations.
If you've got a sophisticated AI/ML device and need full service regulatory expertise that moves at the speed and certainty, Innolitics is the only call worth making.

Terri Kim
Terri Kim, Head of Strategy and Corporate Development at Lunit